Market Tracker

05/24 5:16pm ET

Perrigo Company PLC (NYSE:PRGO)

96.26
Delayed Data
As of 4:02pm ET
 +2.76 / +2.95%
Today’s Change
84.85
Today|||52-Week Range
199.01
-33.48%
Year-to-Date
PRGO Regular Dividend: PRGO will begin trading ex-dividend on 05/25/16 with a $0.145 dividend payable to shareholders of record as of 05/27/16.
Examining the Current State of Health Care and Skin Care Stocks
May 23 / GuruFocus News - Paid Partner Content
Perrigo (PRGO) Tops Q1 Earnings, 2016 Earnings View Intact
May 12 / Zacks.com - Paid Partner Content
Valeant to Evaluate Sales of Noncore Assets
May 23 / TheStreet.com - Paid Partner Content
Perrigo (PRGO) Beats Q1 Earnings and Revenue Estimates
May 12 / Zacks.com - Paid Partner Content
Investors Comforted as Perrigo Sticks to Forecast
May 17 / TheStreet.com - Paid Partner Content
Bill Ackman admits fault in Valeant investment
Apr 27 / FT.com - Paid Partner Content

Today’s Trading

Previous close93.50
Today’s open94.16
Day’s range93.95 - 96.33
Volume2,296,240
Average volume (3 months)2,521,317
Market cap$13.4B
Dividend yield0.60%
Data as of 4:02pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)-95.67%
Earnings growth (this year)--
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+36.36%
P/E ratio20.3
Price/Sales3.82
Price/Book1.33

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+2.44+2.85%
INCYIncyte Corp+0.59+0.73%
MDVNMedivation Inc+1.16+1.91%
VRXValeant Pharmaceutic...-0.10-0.38%
Data as of 4:00pm ET, 05/24/2016

Financials

Next reporting dateAugust 31, 2016
EPS forecast (this quarter)$2.12
Annual revenue (last year)$5.5B
Annual profit (last year)$11.2M
Net profit margin0.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President &
Chief Executive Officer
John T. Hendrickson
Chief Financial Officer &
Executive Vice President
Judy L. Brown
Corporate headquarters
Dublin, Dublin

Forecasts